Miaomiao Li

Miaomiao Li


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2025 in Medicine
Verified
Journal Article
Open access
ZYZhensong Mb Yang
Zhensong Mb Yang
FJFangjie Jiang
Fangjie Jiang
MJMi Jian
Mi Jian
YLYang Mb Liu
Yang Mb Liu
YZYifei Mm Zhang
Yifei Mm Zhang
LJLixin Jiang
Lixin Jiang
Patients with gastrointestinal surgery have a higher incidence of infection-related complications than the rest of those who undergo clean cut surgery. It can lead to a worse prognosis for patients. This study aimed to assess the association between glycemic variability (GV) and postoperative infection-related complications of gastrointestinal cancer patients. A total of 438 patients were included in this study. Using univariate and multivariate regression analyses, the risk factors for postoperative complications were determined. And nomogram prediction models were constructed through machine learning. The performance of the nomogram was assessed with respect to the calibration curves. Univariate and multivariate regression analysis showed that high GV on post operation day (POD)1 (P < .001), high leukocytes on POD4 (P = .003 < .01) and alcohol consumption (P = .005 < .01) were independent risk factors for postoperative infection-related complications in patients with gastrointestinal cancers. The area under the curve (AUC) showed that these 3 prediction models established through logistic regression (AUC = 0.81), XGBoost (AUC = 0.82) and random forest (AUC = 0.78) all performed well. Our study confirmed that higher GV on POD1 were independent risk factors for postoperative infection-related complications within 30 days of surgery in patients with gastrointestinal cancers. And the nomogram prediction model confirmed its capable for predicting infection-related complications.

19 August 2026 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Open access
PDF file
RCRuyue Chen
Ruyue Chen
TGTianxiang Geng
Tianxiang Geng
PXPeng Xiao
Peng Xiao
YZYifei Zhang
Yifei Zhang
XWXixun Wang
Xixun Wang
MJMi Jian
Mi Jian
Background Immunotherapy has become a promising strategy for gastric cancer, yet predicting treatment response remains challenging. We developed an exploratory, biologically informed machine learning framework integrating peri-treatment serum biomarkers and clinical variables, with candidate cytokines informed by an in vitro patient-derived organoids (PDOs)–cancer-associated fibroblasts (CAFs)–T cells co-culture platform, to assess pathological response to PD-1 inhibitor (PD-1i)-based therapy in gastric cancer. Methods Data from 125 patients receiving PD-1i were analyzed. Serum samples collected before and after immunotherapy were tested for cytokines. Eighteen successfully established PDOs-CAFs-T cells co-culture models were used for cytokine profiling and to identify seven candidate cytokines. These cytokines were subsequently measured in paired serum samples from the 125-patient clinical cohort and combined with clinicopathological variables for machine learning model development. Tumor Regression Grade (TRG) served as the binary outcome variable, representing patients with good versus poor/no tumor regression. Experimental and clinical data were used to train predictive models with multiple algorithms, including CatBoost and several other machine learning methods. Model performance was assessed by tenfold cross-validation, ROC, precision-recall (PR) Curve, and decision curve analyses. Feature importance was interpreted using Shapley additive explanations (SHAP) and visualized using decision tree. Results The PDOs-CAFs-T cells co-culture platform showed cytokine-change trends that were generally concordant with those observed in patient serum after treatment. 10 key predictors were identified, including pre-/post-treatment maximum diameter, ycT/ycN stages, and pre- or post-treatment cytokines (IFN-α2, IL-2, IL-6, IL-8, MCP-1). In the internal testing set, the tuned CatBoost model achieved an AUC of 0.845. SHAP analysis revealed post-treatment maximum diameter and cytokine profiles as the most influential features. Decision trees clearly and interpretably present the model. Conclusion This study presents an exploratory, biologically informed machine learning framework for peri-treatment assessment of pathological response in gastric cancer. The PDOs-CAFs-T cells co-culture platform provided biological context for candidate cytokine selection.

4 October 2024 in Medicine
Verified
Journal Article
Open access
ZYZengwu Mm Yao
Zengwu Mm Yao
JWJinhui Mm Wu
Jinhui Mm Wu
MLMiaomiao Li
Miaomiao Li
JHJunping Mb Han
Junping Mb Han
RCRuyue Mm Chen
Ruyue Mm Chen
LJLixin Jiang
Lixin Jiang
This study aimed to assess the impact of surgeons’ annual volume and insulin-like growth factor-like family member 2 (IGFL2) expression on gastric cancer prognosis. Clinicopathological data from 475 patients who underwent D2 lymph node dissection were analyzed. IGFL2 expression was evaluated using immunohistochemistry. Patients were divided into training (70%) and validation (30%) groups. Univariate and multivariate Cox regression identified risk factors for overall survival (OS) and disease-free survival (DFS), leading to a clinical prediction model. Model performance was evaluated using C-index. High IGFL2 expression and low surgical volume independently predicted poorer OS and DFS (hazard ratio = 2.13, 2.17, all P < .01). Surgeons performing >26 cases annually had higher OS and DFS (hazard ratio = 1.65, 1.58, all P < .01). Nomograms integrating surgical volume, IGFL2 expression, grade, TNM staging, and carcinoembryonic antigen showed superior predictive accuracy for OS and DFS compared to TNM alone, with robust C-indices and area under the curve values. Surgeons’ annual volume and IGFL2 expression independently predict gastric cancer prognosis, emphasizing the need for specialized training and further research on IGFL2’s molecular mechanisms to enhance patient outcomes.